Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | PNLIP | P16233 | 1/20 | 0.35 |
| ▸ | F10 | P00742 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21433259 | 1.00 | POLB (0.35) | POLBPNLIPF10ALDH1A1 | |
| SCHEMBL4608105 | 0.84 | ALDH1A1 (0.42) | ALDH1A1 | |
| SCHEMBL812446 | 0.84 | ALDH1A1 (0.42) | ALDH1A1 | |
| SCHEMBL4608110 | 0.84 | ALDH1A1 (0.42) | ALDH1A1 | |
| SCHEMBL4606378 | 0.84 | ALDH1A1 (0.42) | ALDH1A1 | |
| SCHEMBL4606370 | 0.84 | ALDH1A1 (0.42) | ALDH1A1 | |
| SCHEMBL20865951 | 0.79 | LMNA (0.32) | — | |
| SCHEMBL17827415 | 0.79 | LMNA (0.32) | — | |
| SCHEMBL21433258 | 0.77 | GAA (0.40) | ALDH1A1 | |
| SCHEMBL17821217 | 0.77 | GAA (0.40) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3024427-B1 | DERIVATIVES OF 2,2,6-TRIMETHYLCYCLOHEXANE-CARBOXYLATE | TAKASAGO PERFUMERY CO LTD (JP) | 2019-10-09 | — | — | EP | disclosed |
| US-10252975-B2 | Derivatives of 2,2,6-trimethylcyclohexane-carboxylate | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2019-04-09 | — | — | US | disclosed |
| US-20160168074-A1 | DERIVATIVES OF 2,2,6-TRIMETHYLCYCLOHEXANE-CARBOXYLATE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2016-06-16 | — | — | US | disclosed |
| US-20160168074-A1 | DERIVATIVES OF 2,2,6-TRIMETHYLCYCLOHEXANE-CARBOXYLATE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2016-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10252975-B2 | Derivatives of 2,2,6-trimethylcyclohexane-carboxylate | TAS2R13, TAS2R5, TAS2R50 | POLB 3386/4885PNLIP 1082/4885F10 2416/4885 |
| US-20160168074-A1 | DERIVATIVES OF 2,2,6-TRIMETHYLCYCLOHEXANE-CARBOXYLATE | TAS2R13, TAS2R5, TAS2R50 | POLB 3386/4885PNLIP 1082/4885F10 2416/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.